AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
Log in

ASX:ACWActinogen Medical Stock Price, Forecast & News

A$0.02
0.00 (0.00 %)
(As of 05/13/2020)
Add
Compare
Today's Range
A$0.02
Now: A$0.02
A$0.02
50-Day Range
A$0.02
MA: A$0.02
A$0.02
52-Week Range
A$0.01
Now: A$0.02
A$0.07
Volume275,000 shs
Average VolumeN/A
Market Capitalization$21.21 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Actinogen Medical Limited, a biotechnology company, develops treatments for Alzheimer's disease, and the cognitive deficiency associated with other neurological and metabolic diseases in Australia. It is developing Xanamem, a therapy for Alzheimer's disease; and XanADu, a Phase II double-blind, 12-week, randomized, placebo-controlled study to assess the safety, tolerability, and efficacy of Xanamem in subjects with mild dementia due to Alzheimer's disease. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited is based in Sydney, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 2 8964 7401

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.73 million
Cash FlowA$0.01 per share
Book ValueA$0.01 per share

Profitability

Miscellaneous

EmployeesN/A
Outstanding Shares1,116,230,016
Market Cap$21.21 million
Next Earnings DateN/A
OptionableNot Optionable

Receive ACW News and Ratings via Email

Sign-up to receive the latest news and ratings for ACW and its competitors with MarketBeat's FREE daily newsletter.

Actinogen Medical (ASX:ACW) Frequently Asked Questions

How has Actinogen Medical's stock been impacted by COVID-19 (Coronavirus)?

Actinogen Medical's stock was trading at A$0.02 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ACW shares have decreased by 13.6% and is now trading at A$0.02. View which stocks have been most impacted by Coronavirus.

Has Actinogen Medical been receiving favorable news coverage?

News stories about ACW stock have been trending very positive this week, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Actinogen Medical earned a coverage optimism score of 4.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 7.0 out of 10, indicating that recent news coverage is likely to have an effect on the stock's share price in the next several days. View the latest news aboutActinogen Medical.

Who are some of Actinogen Medical's key competitors?

Who are Actinogen Medical's key executives?

Actinogen Medical's management team includes the following people:
  • Dr. John William Ketelbey MBBCH, FFPM, MBA, GAICD, MD, CEO & Director
  • Mr. Peter G. Webse B.Bus, FGIA, FCIS, FCPA, MAICD, Company Sec. (Age 56)
  • Mr. Vincent Ruffles, VP of Drug Devel.

What is Actinogen Medical's stock symbol?

Actinogen Medical trades on the ASX under the ticker symbol "ACW."

What is Actinogen Medical's stock price today?

One share of ACW stock can currently be purchased for approximately A$0.02.

How big of a company is Actinogen Medical?

Actinogen Medical has a market capitalization of $21.21 million and generates $5.73 million in revenue each year.

What is Actinogen Medical's official website?

The official website for Actinogen Medical is www.actinogen.com.au.

How can I contact Actinogen Medical?

The company can be reached via phone at 61 2 8964 7401.

This page was last updated on 6/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.